Candidate : Actualité Candidate en direct - P1 | Bourse Reflex
Accueil > Tags > Candidate

  • Toutes les actualités en rapport avec « Candidate »

02/05 07:30 Candidate - ORAL PRESENTATION OF THERANEXUS AT THE 9TH EUROPEAN CONGRESS ON NARCOLEPSY 5 AND 6 MAY IN MONTPELLIER

26/04 18:00 Candidate - THERANEXUS ANNOUNCES ITS 2017 ANNUAL RESULTS AND PRESENTS AN UPDATE ON THE PROGRESS OF ITS CLINICAL TRIALS

23/04 07:30 Candidate - THN102 OBTAINS INVESTIGATIONAL NEW DRUG STATUS FROM THE FOOD AND DRUG ADMINISTRATION (FDA)

19/04 18:00 Candidate - THERANEXUS ANNOUNCES THE FIRST EUROPEAN APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL WITH THN 102 IN PARKINSON'S DISEASE PATIENTS

19/04 17:45 Candidate - Quantum Genomics enters a new phase of maturity with its BAPAIs Fast Growth strategic plan

29/03 18:00 Candidate - Quantum Genomics publishes its financial results for the year 2017

21/03 07:30 Candidate - THERANEXUS ANNOUNCES A SUCCESSFUL CLINICAL PHARMACOKINETIC STUDY AS PART OF THE DEVELOPMENT OF ITS DRUG CANDIDATES THN201 AND THN101

08/03 17:50 Candidate - Altamir's NAV per share was EUR 21.54 as of 31 December 2017

05/03 18:30 Candidate - Quantum Genomics Secures Operational Flexibility and Growth Capital through Equity Line Financing with Kepler Cheuvreux

15/11 07:30 Candidate - Quantum Genomics announces recruitment of first patients in the NEW-HOPE arterial hypertension study in the United States

27/10 07:30 Candidate - Quantum Genomics receives the Galien MedStartUp award for the innovative design of its NEW-HOPE study

16/10 18:00 Candidate - Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial

03/10 18:15 Candidate - Quantum Genomics Releases 2017 First-Half Financial Results and First Nine Months Business Update

28/09 07:30 Candidate - Theranexus files its registration document as part of its planned Initial Public Offering (IPO) on the Euronext Growth market in Paris

12/07 09:00 Candidate - Avis de Convocation 2e?me Assemble?e Ge?ne?rale des Obligataires

30/06 13:05 Candidate - Artprice takes a major stake in the OTC Art Market which generates a volume of transactions roughly 7 to 9 times higher than the traditional art market

28/06 07:30 Candidate - Quantum Genomics announces the design of its next Phase II trial in arterial hypertension, NEW-HOPE

21/06 14:00 Candidate - Avis de convocations des porteurs d'obligations émises par Infra Park

19/06 07:30 Candidate - Quantum Genomics details positive results from its Phase IIa trial of QGC001 for the treatment of arterial hypertension

07/06 18:20 Candidate - Quantum Genomics to host two upcoming events